The largest database of trusted experimental protocols

Sirnas

Manufactured by RiboBio
Sourced in China

SiRNAs are short, double-stranded RNA molecules that are designed to target and silence specific genes within a cell. They function by binding to complementary mRNA sequences, leading to their degradation or translational repression, thereby reducing the expression of the targeted gene.

Automatically generated - may contain errors

265 protocols using sirnas

1

Silencing DLAT and CDKN2A in Liver Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human liver cancer cells HepG2 and SMMC7721 were procured from the Chinese Cell Bank (Shanghai, China). They were cultured in Dulbecco's modified Eagle's medium (DMEM, Gibco, NY, USA) supplemented with 10% fetal bovine serum and 100 U/ml penicillin-streptomycin, maintained at 37°C with 5% CO 2 . siRNAs targeting DLAT and CDKN2A, along with their respective negative control (NC) sequences, were obtained from RiboBio Co., Ltd. (Guangzhou, China). Cell transfections were carried out using Lipofectamine 3000 reagents (Invitrogen, Grand Island, NY, USA) in accordance with the manufacturer's guidelines. After a 48-hour incubation period with Lipofectamine 3000, the HepG2 and SMMC7721 cells were harvested and utilized for the pertinent experiments. The sequences of siRNAs targeting DLAT were as follows: 5'-CAGTGAATTGTCTTTTAGACAAC-3'; siCDKN2A: 5'-GAUGCUUCGUCUACGAGAATT-3'; si-NC: Ribobio, # siN0000001-1.
+ Open protocol
+ Expand
2

HAUS5 Knockdown in Liver Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human liver cancer cells (HepG2 and Huh7) were obtained from the Chinese Cell Bank (Shanghai, China) and cultured in DMEM (HyClone, Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum and 100 U/ml penicillin‒streptomycin at 37 °C and 5% CO2. Three different small interfering RNAs (siRNAs) for the inhibition of HAUS5 expression and a negative control siRNA were purchased from RiboBio Company (Shanghai, China). The sequences of siRNAs targeting HAUS5 were as follows: siRNA-HAUS5-001: 5′-GGGATCTACTCCACATGAA-3′; siRNA-HAUS5-002: 5′-CCTACATCTTGCAGCATGT-3′. HepG2 and Huh7 cells were infected with Lipofectamine 3000 (Invitrogen, Grand Island, NY, USA) for 48 h and subsequently harvested. The HAUS5 knockdown cell lines were validated using quantitative real-time PCR (qRT‒PCR). The cells were infected with siNC, siHAUS5#1 and siHAUS5#2 to achieve HAUS5 downregulation and used for the relevant experiments.
+ Open protocol
+ Expand
3

Lipofectamine 3000 Transfection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transfections were carried out using the Lipofectamine 3000 Reagent (Invitrogen, Canada) following the manufacturer’s protocol. The small interfering RNAs (siRNAs) targeting ULBP2, TRDV1, and their negative controls were purchased from RiboBio (Guangzhou, China). MDA-MB-231 cells were plated in 96-well plates, when cells reached a confluence of 80%, they were transfected with the fragments or plasmids (0.2 µg/well) by Lipo3000 reagent, according to the protocol. After incubation at 37°C for 24 h, the transfected cells were harvested for subsequent experiments.
+ Open protocol
+ Expand
4

Construction of tRF-1-Ser overexpression and knockdown models

Check if the same lab product or an alternative is used in the 5 most similar protocols
The tRF‐1‐Ser overexpression model was constructed by transfecting synthetic tRF‐1‐Ser mimic, while the scrambled RNA was transfected as a negative control. The tRF‐1‐Ser knockdown model was accomplished by transfecting shtRF‐1‐Ser plasmid packed into lentivirus, and the negative control lentivirus was transfected as the control. Small interfering RNAs (siRNAs) against MBNL1 were used to construct the MBNL1 knockdown model. The MBNL1 overexpression plasmid was purchased from GeneChem. All mimic, siRNAs and lentiviruses were ordered from RIBOBIO. Lipofectamine 3000 reagent (Invitrogen) was used for cell transfection. Lentivirus transfection was performed in accordance with the manufacturer's protocol.
+ Open protocol
+ Expand
5

Transfection of siRNAs and Plasmids

Check if the same lab product or an alternative is used in the 5 most similar protocols
The transfection method was introduced in our previous study 25 (link). The agents in our study were as follows: small interfering RNAs (siRNAs) targeted to GNA14, DNMT1, DNMT3A, and negative control, which were purchased from RiboBio Co., Ltd. (Guangzhou, China). siRNA targeted to HBx and negative control were purchased from Jima Biotechnology Co., Ltd. (Shanghai, China). HBx overexpressed plasmid, HBVpg3 plasmid (GV146-HBx), were purchased from JiKai Gene Co., Ltd (Shanghai, China). Lentivirus containing the complete open reading frame of GNA14 and GFP (Lentivirus -GFP -GNA14) and plasmid containing GNA14 promoter and luciferase reporter (pGL3-GNA14 Promoter wt-LUC, pGL3-GNA14 Promoter mut-LUC) for the dual luciferase reporter system were purchased from AoQian Co., Ltd (Hangzhou, China). The siRNA sequences are listed in Table S1.
+ Open protocol
+ Expand
6

Transfection of siRNA in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
We purchased siRNAs from RiboBio (Guangzhou, China). Cells were seeded in 6-well plates at 50% confluence without antibiotics on the day before transfection. Transfection with si-STAT3 or miRNA negative control #22 (NC) (Ribobio, Guangzhou, China) was performed using Lipofectamine 2000 reagent (Invitrogen, NY, United States). Transfection complexes were prepared according to the manufacturer's instructions. All transfections were carried out according to manufacturers' instructions.
+ Open protocol
+ Expand
7

siRNA Knockdown of DNM1L in LUAD Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Small interference RNAs (siRNAs) were purchased from RiboBio (Guangzhou, China) and used for DNM1L knockdown in LUAD cells. Three siRNAs were transiently transfected into cells by lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) at a concentration of 100 nM. The siRNA sequences: (I) 5'-3': GGAACAAAGTATCTTGCTA; (II) 5'-3': GAAGGGTTATTCCAGTCAA; and (III) 5'-3': GGTTGGAGATGGTGTTCAA.
+ Open protocol
+ Expand
8

Regulation of SCRIB in Colorectal Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Normal epithelial colon cells (NCM460 cells) and human CRC cells, including Lovo, HCT116, SW620, DLD-1 and HT-29 cells, were obtained from American Type Culture Collection. RPMI-1640 medium and McCoy’5A medium (HyClone, Logan, UT, United States) were mixed with 10% fetal bovine serum to culture the DLD-1 and HCT116 cells, respectively. The cells were cultured in a humid incubator, which always maintained a temperature of 37°C and an atmosphere of 5% CO2. The siRNAs targeting SCRIB and the corresponding negative controls (si-NC) were synthesized by RiboBio (Guangzhou, China). The siRNA target sequence (GAAGCAGCTATCCATCCTA) with the highest efficiency for knocking down the expression of SCRIB was cloned into the lentivirus vector pGLV3 to by GeneChem (Shanghai, China). GeneChem Company designed and constructed the SCRIB overexpression plasmid for our study. Lipofectamine 3000 (Invitrogen) was used for the transfection of cells.
+ Open protocol
+ Expand
9

Silencing HSP70 in MARC-145 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
SiRNAs obtained from Ribobio (Guangzhou, China) were designed to interfere with the two mRNAs encoding HSP70 (GenBank accession number AB170713 for HSPA1A and XM_001115060 for HSPA1B). MARC-145 cells were seeded into 6-well plates nearly 24 hours before tansfection. The SiRNAs were transfected into MARC-145 cells with lipofectamine 2000 (Invitrogen) according to the manufacturer’s instruction.
+ Open protocol
+ Expand
10

HCC Tissue Profiling and Silencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 43 paired freshly frozen HCC and corresponding noncancerous tissues were obtained from patients who underwent liver resection at the Hepatic Surgery Center of Tongji Hospital and were used for qRT-PCR. This study was approved by the Medical Ethics Committee of Tongji Hospital and conducted in accordance with the Declaration of Helsinki. The HCC cell line MHCC-97H [97H] was purchased from the China Center for Type Culture Collection (CCTCC, Wuhan, China). The cell lines were cultured in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum (Gibco, Grand Island, NY) and incubated in a humidified atmosphere comprising 5% CO2 at 37 °C. The small interfering RNAs (siRNAs) and si-control were purchased from RiboBio (Guangzhou, China). Lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA) was used for transient transfection according to the manufacturer's protocol. To conduct animal experiments, MHCC-97H cells were transfected with the specific short hairpin RNAs to BBOX1-AS1 (sh-BBOX1-AS1). SiRNA target sequences and sh-BBOX1-AS1 sequence are listed in Additional file 1: Table S1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!